Back
CNR
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Cannon Resources Limited
๐ฆ๐บ ASX
๐ Overview
๐ Performance
๐ต Cost
๐ Esg
๐ค Advanced
๐จโ๐ฉโ๐งโ๐ฆ Community
๐
+ 9.96%
Annual Growth
4 years average annual capital growth
๐ต
$ 500
Minimum Order
Due to regulatory requirements
๐
1
Pearlers Invested
Since January 2020
๐ Overview
Key information
๐ Fund Overview
Cannon Resources Limited
๐ Performance
Price History
+41.27%
1M
All Time
Graph
Table
Unsure how much or often to invest?
๐๏ธ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out โ๐ต Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out โโฑ๏ธ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out โ๐ต Costs
๐ผ
N/A
Management Fee
Included in unit price, not charged by Pearler
๐ธ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐ธ Net fee calculator๐ค Advanced information
Technical Info
๐ฐ Price*
$0.45
*Price may be up to 24 hours old
๐ฉโ๐ฉโ๐ฆ Community Insights
How our community is investing
๐ Pearlers invested in CNR
0
๐ Total Capital Earnings
$-509.84
๐ Average investment frequency
13 weeks
๐ต Average investment amount
$547
โฐ Last time a customer invested in CNR
1055 days
CNR investor breakdown
๐ต Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
๐ถ Age of investors
18 - 25
26 - 34
35 - 90
๐ Legal gender of investors
Female
Male
Pearlers who invest in CNR also invest in...
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
๐ Performance (5Yr p.a)
12.43%
๐ Share price
$16.88 AUD
โณ๏ธ DIVERSIFIED
๐ค TECHNOLOGY
๐ GLOBAL
๐ HIGH PRICE GROWTH
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments or cognitive impairment associated with neurological, psychiatric, and metabolic diseases due to raised cortisol. The company is headquartered in Sydney, New South Wales. The company went IPO on 2007-10-16. The firm is engaged in the development of a therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. The firm is engaged in the development of its lead compound, Xanamem, as a therapy for Alzheimerโs Disease, Major Depressive Disorder, Fragile X Syndrome, and other neurological diseases where reducing cortisol inside brain cells could have a positive impact. Xanamemโs mechanism of action is to block the production of cortisol inside cells through the inhibition of the 11B-HSD1 enzyme in the brain. Xanamem is designed to get into the brain after it is absorbed in the intestines upon swallowing its capsule. The company has studied 11B-HSD1 inhibition by Xanamem in approximately 300 volunteers and patients. The firm conducts a series of Phase II studies in multiple diseases to further confirm and characterize Xanamemโs therapeutic potential.
๐ Performance (5Yr p.a)
10.00%
๐ Share price
$0.03 AUD
๐ HIGH PRICE GROWTH
๐งฌ BIOTECHNOLOGY
CGS
Cogstate Ltd. is a global cognitive science company, which engages in delivering software services to optimize the measurement of cognition in clinical trials, academic research, healthcare and brain injury. The company is headquartered in Melbourne, Victoria. The company went IPO on 2004-02-13. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.
๐ Performance (5Yr p.a)
42.50%
๐ Share price
$2.50 AUD
๐ฉบ HEALTH CARE
๐ HIGH PRICE GROWTH
Flight Centre Travel Group Ltd. is engaged in providing travel retailing, wholesaling and corporate travel management services. The company is headquartered in Brisbane, Queensland and currently employs 12,411 full-time employees. The firm's principal activities consist of leisure travel retailing and corporate travel management, plus in-destination travel experience businesses including tour operations, hotel management, destination management companies (DMCs) and wholesaling. Its segments include Leisure, Corporate, and Other. The Leisure segment combines the retail storefront and online brands for retail customers, luxury travel brands Travel Associates and Scott Dunn, independent agents and complementary offerings. The Corporate segment includes the FCM brand, corporate traveler and other corporate customer brands. The Other segment includes Brisbane-based and other support businesses, including Supply, that support the global network and also includes travel management services which incorporate touring, ground-handling and hotels. Its brands include Flight Centre, Aunt Betty, ignite, and Scott Dunn, among others.
๐ Performance (5Yr p.a)
-2.37%
๐ Share price
$12.00 AUD
๐จ HOTELS, RESTAURANTS & LEISURE
HACK.AX was created on 2016-08-30 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The fund aims to track the performance of an index (before fees and expenses) that provides exposure to the leading companies in the global cybersecurity sector.
๐ Performance (5Yr p.a)
20.78%
๐ Share price
$15.68 AUD
๐ HIGH PRICE GROWTH
๐ค TECHNOLOGY
๐ฆ๐บ EX AUSTRALIA
Want more shares? Try these...
Chorus Ltd. operates as a telecommunications infrastructure company. The Companyโs product portfolio includes a range of wholesale broadband, data, and voice services across a mix of regulated and commercial products. The company operates in the segment of nationwide fixed-line communications infrastructure. Its services include fiber and copper connections, providing access to the fixed-line network for Internet connectivity. The value-added network services enhance access to the fixed-line network for improved Internet connections through backhaul and handover link services, enabling connectivity across wider areas. Infrastructure services offer physical storage and site-sharing rental options for the co-location of third-party or shared assets. Field services cover installation, wiring, and consultation support. The Companyโs subsidiary is Chorus New Zealand Limited.
๐ Performance (5Yr p.a)
0.71%
๐ Share price
$8.16 AUD
๐ COMMUNICATIONS